Showing results (41-50 of 79) with videos related to

Sort By:
Pageof 8
The Oncologist|March 16, 2026
Identification of new prognostic molecular markers in glioblastoma: a single-center retrospective studyAdèle Meola, Bertille Segier, Aurore Siegfried, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 23, 2018
Reappraisal of HER2 status in the spectrum of advanced urothelial carcinoma: a need of guidelines for treatment eligibilityAnissa Moktefi, Damien Pouessel, Jing Liu, et al.
European Journal of Clinical Pharmacology|January 15, 2020
Association between clinically relevant toxicities of pazopanib and sunitinib and the use of weak CYP3A4 and P-gp inhibitorsCamille Azam, Pauline Claraz, Christine Chevreau, et al.
Critical Reviews in Oncology/Hematology|July 28, 2026
Squamous cell carcinoma of the bladder: Current evidence, therapeutic challenges, and research perspectives from the French AVENTUR groupJérémy Mercier, Pierre Cornillon, Philippe Barthélémy, et al.
Journal of Clinical Medicine|June 27, 2020
Survival Outcomes of Patients with Pathologically Proven Positive Lymph Nodes at Time of Radical Cystectomy with or without Neoadjuvant ChemotherapyGuillaume Ploussard, Benjamin Pradere, Jean-Baptiste Beauval, et al.
Cancer Medicine|April 21, 2025
Patient Versus Clinician Reported Symptoms Agreement in Advanced Metastatic Bladder Cancer PatientsSoufyan Annakib, Emma Di Méglio, Yona Dibert-Bekoy, et al.
The Journal of Pathology|October 6, 2021
Multilayer spectrum of intratumoral heterogeneity in basal bladder cancerNanor Sirab, Damien Drubay, Pascale Maillé, et al.
European Journal of Cancer (Oxford, England : 1990)|January 3, 2016
Standard or accelerated methotrexate, vinblastine, doxorubicin and cisplatin as neoadjuvant chemotherapy for locally advanced urothelial bladder cancer: Does dose intensity matter?Damien Pouessel, Sylvie Chevret, Frédéric Rolland, et al.
BJUI Compass|July 21, 2025
Primary urethral cancer: Treatment patterns, responses and survival in localized, advanced and metastatic patientsIlfad Blazevic, Aude Fléchon, Géraldine Pignot, et al.
Clinical Genitourinary Cancer|October 4, 2018
Denosumab Toxicity When Combined With Anti-angiogenic Therapies on Patients With Metastatic Renal Cell Carcinoma: A GETUG StudyAline Guillot, Charlotte Joly, Philippe Barthélémy, et al.
Pageof 8